Collegium Pharmaceutical, Inc.COLL announced that its abuse deterrent analgesic, Xtampza ER (oxycodone extended release capsules), was unanimously supported for approval by a couple of FDA advisory panels the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety